Drug Shortage Report for INTRON A
Report ID | 15541 |
Drug Identification Number | 02238675 |
Brand name | INTRON A |
Common or Proper name | interferon alfa-2b solution for injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INTERFERON ALFA-2B |
Strength(s) | 10000000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 1X10MIU HSA FREE VIAL |
ATC code | L03AB |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-08-03 |
Actual start date | |
Estimated end date | 2017-08-04 |
Actual end date | 2017-08-02 |
Shortage status | Avoided shortage |
Updated date | 2017-10-10 |
Company comments | Limited Quantities available / Quantités limitées disponibles |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-10-10 | English | Compare |
v4 | 2017-08-02 | English | Compare |
v3 | 2017-07-12 | French | Compare |
v2 | 2017-07-12 | French | Compare |
v1 | 2017-07-12 | English | Compare |
Showing 1 to 5 of 5